Author

A. James Mixson

University of Maryland - Cited by 4,545 - gene therapy

Biography

Dr. A. James Mixson is currentlyassistnat professor of pathology at Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. He has published many articles in his career. He has completed his Masters from Imo State University, Nigeria.
Title
Cited by
Year
Advances in Delivery Systems for Doxorubicin
N Zhao, M Woodle, AJ MixsonJournal of Nanomedicine and Nanotechnology 9, 519, 2018201
185
2018
Peptide-based antifungal therapies against emerging infections
A Matejuk, Q Leng, MD Begum, MC Woodle, P Scaria, ST Chou, ...Drugs of the Future 35 (3), 197, 2010201
167
2010
Branched histidine copolymers and methods for using same
AJ MixsonUS Patent 7,070,807, 2006200
103
2006
Branched histidine copolymers and methods for using same
AJ MixsonUS Patent 7,070,807, 2006200
103
2006
Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growth
Z Yan, H Zou, F Tian, JR Grandis, AJ Mixson, PY Lu, LY LiMolecular cancer therapeutics 7 (6), 1355-1364, 2008200
96
2008
Histidine copolymer and methods for using same
AJ MixsonUS Patent 7,163,695, 2007200
88
2007
Advances in systemic siRNA delivery
Q Leng, MC Woodle, PY Lu, AJ MixsonDrugs of the future 34 (9), 721, 2009200
80
2009
Enhanced silencing and stabilization of siRNA polyplexes by histidine-mediated hydrogen bonds
ST Chou, K Hom, D Zhang, Q Leng, LJ Tricoli, JM Hustedt, A Lee, ...Biomaterials 35 (2), 846-855, 2014201
67
2014
Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts
Q Leng, P Scaria, P Lu, MC Woodle, AJ MixsonCancer gene therapy 15 (8), 485-495, 2008200
58
2008
Histidine-lysine peptides as carriers of nucleic acids.
Q Leng, L Goldgeier, J Zhu, P Cambell, N Ambulos, AJ MixsonDrug news & perspectives 20 (2), 77-86, 2007200
55
2007
Synthetic Histidine-Rich Peptides Inhibit Candida Species and Other Fungi In Vitro: Role of Endocytosis and Treatment Implications
J Zhu, PW Luther, Q Leng, AJ MixsonAntimicrobial agents and chemotherapy 50 (8), 2797-2805, 2006200
49
2006
Simultaneous silencing of TGF-β1 and COX-2 reduces human skin hypertrophic scar through activation of fibroblast apoptosis
J Zhou, Y Zhao, V Simonenko, JJ Xu, K Liu, D Wang, J Shi, T Zhong, ...Oncotarget 8 (46), 80651, 2017201
43
2017
Vaccines targeting the neovasculature of tumors
A Matejuk, Q Leng, ST Chou, AJ MixsonVascular cell 3 (1), 1-21, 2011201
40
2011
Surface-modified HK: siRNA nanoplexes with enhanced pharmacokinetics and tumor growth inhibition
ST Chou, Q Leng, P Scaria, JD Kahn, LJ Tricoli, M Woodle, AJ MixsonBiomacromolecules 14 (3), 752-760, 2013201
36
2013
Increased tumor distribution and expression of histidine‐rich plasmid polyplexes
Q Leng, ST Chou, PV Scaria, MC Woodle, AJ MixsonThe journal of gene medicine 16 (9-10), 317-328, 2014201
36
2014
Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo
ST Chou, Q Leng, P Scaria, M Woodle, AJ MixsonCancer Gene Therapy 18 (10), 707-716, 2011201
33
2011
A branched histidine/lysine peptide, H2K4b, in complex with plasmids encoding antitumor proteins inhibits tumor xenografts
Q Leng, P Scaria, OB Ioffe, M Woodle, AJ MixsonThe Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2006200
30
2006
The neuropilin‐1 receptor mediates enhanced tumor delivery of H2K polyplexes
Q Leng, AJ MixsonThe journal of gene medicine 18 (7), 134-144, 2016201
28
2016
The multifaceted histidine-based carriers for nucleic acid delivery: advances and challenges
J He, S Xu, AJ MixsonPharmaceutics 12 (8), 774, 2020202
25
2020
Highly branched HK peptides as effective carriers of siRNA
A MixsonUS Patent 7,772,201, 2010201
21
2010

Referred From: https://scholar.google.com/citations?user=htDTpgwAAAAJ&hl=en

Cited by
Citations 4545
h-index 35
i10-index 52
Open Access Journals